Jan 11 (Reuters) - Melinta Therapeutics, Inc.:
* THE MEDICINES COMPANY REPORTS 10.6 PERCENT PASSIVE STAKE IN MELINTA THERAPEUTICS INC AS OF JAN. 5, 2018 - SEC FILING‍​ Source text: ( bit.ly/2muRQBT ) Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.